source
- Myriad Genetics sells prenatal testing business to Labcorp for $210 millionMyriad Genetics announced it will divest its Prenatal Health testing division to Labcorp, receiving $210 million in cash. The transaction includes Myriad's Prequel, Foresight, SneakPeek and FirstG…
- FDA device officials prioritize hiring after layoffs, express optimism for upcoming MDUFA VI agreementTop officials from the FDA's Center for Devices and Radiological Health spoke at a town‑hall session during The MedTech Conference. They said the agency is concentrating on rebuilding staff after a…